Brenda Marex - Profile and Investment Details

Investor Profile

Brenda Marex is a Micro VC based in United States with a diverse investment portfolio that includes companies such as Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive, Celleration, Oxyrane UK, Ikonisys, NorthSea Therapeutics, ProterixBio, Lightwire, Vorago Technologies, Ralexar Therapeutics, Ario Pharma, ChromaCure, Resolve Therapeutics, Cambridge Epigenetix, Ovizio, DUST Identity, BioVex, BrightVolt, Seahorse Bioscience, Svelte Medical Systems, Morrow Optics, Akarna Therapeutics, Escalier Biosciences, Ventyx Biosciences, Fuzzy Logix, PlanetIQ, Zeotap, Juventas Therapeutics, Novadip Biosciences, Light Sciences Oncology, Achronix Semiconductor, BioProcessors, Dezima Pharma, TherOx, TigerConnect, Ception Therapeutics, Caringo, ISORG, EXTEN Technologies, FlowCardia, NeXeption. Over time, Brenda Marex has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Brenda Marex is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Cybersecurity, Information Technology (IT), Electronics, Biotech, Internet of Things (IoT), Medical Device, Software, Manufacturing, Healthcare, Biotechnology, Supply Chain Management, Genomics, Satellite Communication, Aerospace, Marketing, Digital Marketing, Nanotechnology, Medical, SaaS, Battery, Therapeutics, Biopharma, Security may find it worthwhile to explore potential connections with Brenda Marex, as their portfolio suggests a familiarity and interest in this area.

Understanding Brenda Marex’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.